Survey optimistic on med ed funding

Share this article:
Funding for medical education next year will likely increase or remain stable, according to a Cutting Edge Information survey.

For 2007, 41% of surveyed drug firms predicted a spending hike, 29% forecast a decrease and 29% expected no change. Those promising to spend more said they intend to add events.

“Very few companies are looking to decrease funding or the number of events,” said Elio Evangelista, senior research analyst, Cutting Edge. Why the grantor optimism? “Everybody understands…the rules and the lay of the land and what the repercussions would be [for] not following along with industry practices.”

Share this article:

Email Newsletters

More in News

Eli Lilly and BI's Jardiance hits shelves

Eli Lilly and BI's Jardiance hits shelves

The new SGLT-2 inhibitor is on shelves less than a month after FDA approval.

PhRMA Urges Court to Reject Off-Label Promotion Case

PhRMA Urges Court to Reject Off-Label Promotion Case

The Pharmaceutical Research and Manufacturers of America (PhRMA) says a California federal court should dismiss a whistleblower's False Claims Act suit against three drug companies on First Amendment grounds

Five things for Pharma Marketers to know: Tuesday, August 26

Five things for Pharma Marketers to know: Tuesday, ...

Merck and Pfizer pursue new pembrolizumab research, black box warnings are linked to fewer court visits, and the WHO says it needs $430M to fight Ebola.